Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia.

Pharmacogenetics and genomics - 1 Apr 2015

Wang Dai, Fu Dong-Jing, Wu Xiaodong, Shapiro Alice, Favis Reyna, Savitz Adam, Chung Hedy, Alphs Larry, Gopal Srihari, Haas Magali, Cohen Nadine, Li Qingqin

Abstract excerpt

OBJECTIVE: Clinical response to antipsychotic medications can vary markedly in patients with schizophrenia. Identifying genetic variants associated with treatment response could help optimize patient care and outcome. To this end, we carried out a large-scale candidate gene study to identify genetic risk factors predictive of paliperidone efficacy. PATIENTS AND METHODS: A central nervous system custom chip...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Isoxazoles

Share to Neuregulin-1

Share to Pyrimidines

Share to Receptor, ErbB-4

Share to Schizophrenia

Source

Identifiers

PMID: 25714000
DOI: 10.1097/FPC.0000000000000122

Genes

ERBB4
NRG1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia.PMID 25714000Read ↗

Genome-wide association study of paliperidone efficacy.Semantic proximity Read ↗

Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials.Semantic proximity Read ↗

Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches.Semantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.Semantic proximity Read ↗

Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.Semantic proximity Read ↗

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia PatientsSemantic proximity Read ↗

Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.Semantic proximity Read ↗

Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.Semantic proximity Read ↗

Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.Semantic proximity Read ↗

Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.Semantic proximity Read ↗

Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.